HMGB1P37: A Drug Target / Disease Biomarker (G100132863)

Target Name: HMGB1P37

NCBI ID: G100132863

HMGB1P37

Other Name(s): High mobility group box 1 pseudogene 37 | high mobility group box 1 pseudogene 37

HMGB1P37: A Drug Target / Disease Biomarker

HMGB1P37 is a protein that is expressed in various tissues throughout the body, including the heart, lungs, and kidneys. It is a key component of the extracellular matrix (ECM), which is a complex structure that provides support and structure to various tissues and organs. HMGB1P37 has been shown to play a role in the regulation of cellular processes that are important for tissue repair and regeneration, and it has potential as a drug target or biomarker.

One of the key functions of HMGB1P37 is its role in the regulation of cell adhesion. This is important for the development and maintenance of tissues and organs, as well as for the regulation of the immune response. HMGB1P37 helps to regulate the activity of cells that are involved in cell adhesion, and this is critical for the formation of tissues and organs during development.

Another function of HMGB1P37 is its role in the regulation of cell signaling. This is important for the regulation of cellular processes that are important for tissue growth and repair, as well as for the regulation of the immune response. HMGB1P37 has been shown to play a role in the regulation of several signaling pathways that are involved in the development and maintenance of tissues and organs, including the TGF-β pathway.

In addition to its role in cell adhesion and signaling, HMGB1P37 is also involved in the regulation of cellular processes that are important for the regulation of inflammation. This is important for the regulation of the immune response, and for the regulation of tissue repair and regeneration. HMGB1P37 has been shown to play a role in the regulation of several signaling pathways that are involved in inflammation, including the NF-kappa-B pathway.

Overall, HMGB1P37 is a protein that is involved in a wide range of cellular processes that are important for the development and maintenance of tissues and organs. As a result, it has potential as a drug target or biomarker for a variety of diseases. Further research is needed to fully understand the role of HMGB1P37 in these processes, and to develop effective treatments based on this protein.

Protein Name: High Mobility Group Box 1 Pseudogene 37

The "HMGB1P37 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HMGB1P37 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets